The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 07, 2025
Filed:
Jun. 06, 2019
Applicant:
Albert Einstein College of Medicine, Bronx, NY (US);
Inventors:
Jonathan R. Lai, Dobbs Ferry, NY (US);
Jose Quiroz, Bronx, NY (US);
Ryan Malonis, Bronx, NY (US);
Margaret Kielian, Dobbs Ferry, NY (US);
Assignee:
Albert Einstein College of Medicine, Bronx, NY (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); A61K 33/242 (2019.01); A61K 39/42 (2006.01); A61P 31/14 (2006.01); C07K 16/10 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 33/242 (2019.01); A61K 39/42 (2013.01); A61P 31/14 (2018.01); C07K 16/1081 (2013.01); C12N 7/00 (2013.01); A61K 2039/505 (2013.01); A61K 2039/525 (2013.01);
Abstract
Provided are high affinity anti-alphavirus antibodies or alphavirus-binding fragments thereof, as well as methods of use and devices employing such antibodies and/or fragments. Further provided are complementarity determining region (CDR) sequences of variable domain light chain (VL) and variable domain heavy chain (VH) sequences, and the methods of using the high affinity anti-alphavirus antibodies for treating different types of alphavirus infections.